Literature DB >> 25133892

Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma.

K Kato1, Y Ohno2, T Kamimura3, H Kusumoto2, T Tochigi2, F Jinnouchi1, K Kohno1, T Kuriyama1, H Henzan4, K Takase4, I Kawano4, M Kadowaki4, R Nawata4, T Muta4, T Eto4, H Iawasaki5, K Ohshima6, T Miyamoto1, K Akashi7.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25133892     DOI： 10.1038/bmt.2014.189

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis.

Authors:  M Yamaguchi; M Kimura; Y Watanabe; M Taniguchi; M Masuya; S Kageyama; N Katayama; T Ohno; K Kita; H Shiku
Journal:  Bone Marrow Transplant       Date:  2001-01       Impact factor: 5.483

2.  Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

Authors:  M Koizumi; M Nishimura; A Yokota; S Munekata; T Kobayashi; Y Saito
Journal:  Bone Marrow Transplant       Date:  2001-05       Impact factor: 5.483

3.  Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.

Authors:  Kazuyuki Shimada; Takuhei Murase; Kosei Matsue; Masataka Okamoto; Naoaki Ichikawa; Norifumi Tsukamoto; Nozomi Niitsu; Hiroshi Miwa; Hideki Asaoku; Hiroshi Kosugi; Ako Kikuchi; Morio Matsumoto; Yoshio Saburi; Yasufumi Masaki; Kazuhito Yamamoto; Motoko Yamaguchi; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  Cancer Sci       Date:  2010-03-06       Impact factor: 6.716

4.  Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.

Authors:  Patrick J Stiff; Joseph M Unger; James R Cook; Louis S Constine; Stephen Couban; Douglas A Stewart; Thomas C Shea; Pierluigi Porcu; Jane N Winter; Brad S Kahl; Thomas P Miller; Raymond R Tubbs; Deborah Marcellus; Jonathan W Friedberg; Kevin P Barton; Glenn M Mills; Michael LeBlanc; Lisa M Rimsza; Stephen J Forman; Richard I Fisher
Journal:  N Engl J Med       Date:  2013-10-31       Impact factor: 91.245

5.  Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?

Authors:  Andrés J M Ferreri; Giuseppina P Dognini; Silvia Govi; Roberto Crocchiolo; Maria Bouzani; Claudia R Bollinger; Michel D'Incan; Emmanuel Delaporte; Mehdi Hamadani; Fabrice Jardin; Magdalena Martusewicz-Boros; Mauro Montanari; Arpad Szomor; Emanuele Zucca; Franco Cavalli; Maurilio Ponzoni
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

Review 6.  Presentation and management of intravascular large B-cell lymphoma.

Authors:  Kazuyuki Shimada; Tomohiro Kinoshita; Tomoki Naoe; Shigeo Nakamura
Journal:  Lancet Oncol       Date:  2009-09       Impact factor: 41.316

7.  The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma.

Authors:  Andrés J M Ferreri; Giuseppina P Dognini; Osnat Bairey; Arpad Szomor; Carlos Montalbán; Barbara Horvath; Judit Demeter; Lilj Uziel; Riccardo Soffietti; John F Seymour; Achille Ambrosetti; Rein Willemze; Maurizio Martelli; Giuseppe Rossi; Anna Candoni; Amalia De Renzo; Claudio Doglioni; Emanuele Zucca; Franco Cavalli; Maurilio Ponzoni
Journal:  Br J Haematol       Date:  2008-08-10       Impact factor: 6.998

8.  Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.

Authors:  Kazuyuki Shimada; Kosei Matsue; Kazuhito Yamamoto; Takuhei Murase; Naoaki Ichikawa; Masataka Okamoto; Nozomi Niitsu; Hiroshi Kosugi; Norifumi Tsukamoto; Hiroshi Miwa; Hideki Asaoku; Ako Kikuchi; Morio Matsumoto; Yoshio Saburi; Yasufumi Masaki; Motoko Yamaguchi; Shigeo Nakamura; Tomoki Naoe; Tomohiro Kinoshita
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
  8 in total
  4 in total

1.  Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.

Authors:  J Meissner; H Finel; S Dietrich; A Boumendil; E Kanfer; G Laboure; M Abecasis; J Cornelissen; J Delage; J Finke; U Hess; H Ludwig; M Mohty; T Pabst; P Pioltelli; S Robinson; P Samaras; S Montoto; P Dreger
Journal:  Bone Marrow Transplant       Date:  2016-12-19       Impact factor: 5.483

2.  Intravascular Large B Cell Lymphoma - Still a Diagnostic Dilemma.

Authors:  Abuzar A Asif; Manisha Tharoor; Jacqueline L Fischer
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-01-31

3.  Intravascular large B-cell lymphoma: an elusive diagnosis with challenging management.

Authors:  Akash Mukherjee; Ibrahim F Ibrahim
Journal:  J Community Support Oncol       Date:  2018

Review 4.  Intravascular Large B-cell lymphoma: A case series and review of literatures.

Authors:  Yuen-Chin Ong; Hsiao-Wen Kao; Wen-Yu Chuang; Yu-Shin Hung; Tung-Liang Lin; Hung Chang; Ming-Chung Kuo
Journal:  Biomed J       Date:  2020-04-25       Impact factor: 4.910
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.